Literature DB >> 21465263

Modifications of p53 and the DNA damage response in cells expressing mutant form of the protein huntingtin.

Jennifer L Illuzzi1, Cassie A Vickers, Eric B Kmiec.   

Abstract

Huntington's disease (HD) occurs through an expansion of the trinucleotide repeat in the HD gene resulting in the lengthening of the polyglutamine stretch within the N terminus of the protein, huntingtin (Htt). While the function of the protein is still being fully elucidated, we have shown that genomic DNA damage is associated with the expression of mutant Htt (mHtt) in a time-dependent fashion. With the accumulation of mHtt and its development into a micro-aggregated complex, the initiation of genomic damage engages a cellular stress signal that activates the DNA damage and stress response pathway. Here we explore the modifications and activation of p53 and keystone regulators of the cell stress response pathway using expression of a fragment of mHtt in HEK293T cells. We find an increase in phosphorylated p53 at serine 15 (S15), diminished acetylation at lysine 382 (K382), altered ubiquitination pattern, and oligomerization activity as a function of mHtt expression. As one might predict, upstream regulators of p53, such as CREB-binding protein/p300 and MDM2, are also seen to be affected by the expression of mHtt, albeit in different ways. These data suggest a possible relationship between p53 and the slow accumulation of DNA damage resulting from the expression of mHtt. The lack of a proper p53-mediated signaling cascade or its alteration in the presence of DNA damage may contribute to the slow progression of cellular dysfunction which is a hallmark of HD pathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21465263     DOI: 10.1007/s12031-011-9516-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  60 in total

1.  Huntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders.

Authors:  P S Harper
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets.

Authors:  Weiguo Zhai; Hyunkyung Jeong; Libin Cui; Dimitri Krainc; Robert Tjian
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

3.  Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding.

Authors:  Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  EMBO J       Date:  2009-04-02       Impact factor: 11.598

4.  p53 suppresses the self-renewal of adult neural stem cells.

Authors:  Konstantinos Meletis; Valtteri Wirta; Sanna-Maria Hede; Monica Nistér; Joakim Lundeberg; Jonas Frisén
Journal:  Development       Date:  2006-01       Impact factor: 6.868

5.  Enhanced phosphorylation of p53 by ATM in response to DNA damage.

Authors:  S Banin; L Moyal; S Shieh; Y Taya; C W Anderson; L Chessa; N I Smorodinsky; C Prives; Y Reiss; Y Shiloh; Y Ziv
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

6.  Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.

Authors:  Haibing Jiang; Michelle A Poirier; Yideng Liang; Zhong Pei; Charlotte E Weiskittel; Wanli W Smith; Donald B DeFranco; Christopher A Ross
Journal:  Neurobiol Dis       Date:  2006-09       Impact factor: 5.996

7.  Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis.

Authors:  Juliette D Godin; Kelly Colombo; Maria Molina-Calavita; Guy Keryer; Diana Zala; Bénédicte C Charrin; Paula Dietrich; Marie-Laure Volvert; François Guillemot; Ioannis Dragatsis; Yohanns Bellaiche; Frédéric Saudou; Laurent Nguyen; Sandrine Humbert
Journal:  Neuron       Date:  2010-08-12       Impact factor: 17.173

8.  Interaction of Huntington disease protein with transcriptional activator Sp1.

Authors:  Shi-Hua Li; Anna L Cheng; Hui Zhou; Suzanne Lam; Manjula Rao; He Li; Xiao-Jiang Li
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

9.  p53 regulates hematopoietic stem cell quiescence.

Authors:  Yan Liu; Shannon E Elf; Yasuhiko Miyata; Goro Sashida; Yuhui Liu; Gang Huang; Silvana Di Giandomenico; Jennifer M Lee; Anthony Deblasio; Silvia Menendez; Jack Antipin; Boris Reva; Andrew Koff; Stephen D Nimer
Journal:  Cell Stem Cell       Date:  2009-01-09       Impact factor: 24.633

10.  Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD).

Authors:  Larissa Arning; Peter H Kraus; Carsten Saft; Jürgen Andrich; Jörg T Epplen
Journal:  BMC Med Genet       Date:  2005-10-03       Impact factor: 2.103

View more
  11 in total

1.  Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease.

Authors:  Jose F Moruno-Manchon; Ndidi-Ese Uzor; Maria P Blasco-Conesa; Sishira Mannuru; Nagireddy Putluri; Erin E Furr-Stimming; Andrey S Tsvetkov
Journal:  Hum Mol Genet       Date:  2017-04-01       Impact factor: 6.150

Review 2.  Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.

Authors:  Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2021-09-14       Impact factor: 5.590

3.  Tolfenamic acid inhibits ROS-generating oxidase Nox1-regulated p53 activity in intrastriatal injection of malonic acid rats.

Authors:  Xin Yang; Heling Zhang; Tong Qu; Yi Wang; Yongxian Zhong; Yuchen Yan; Xuefei Ji; Tiayan Chi; Peng Liu; Libo Zou
Journal:  J Physiol Sci       Date:  2022-07-18       Impact factor: 2.257

4.  Inhibition of autophagy via p53-mediated disruption of ULK1 in a SCA7 polyglutamine disease model.

Authors:  Xin Yu; Andrés Muñoz-Alarcón; Abiodun Ajayi; Kristin E Webling; Anne Steinhof; Ülo Langel; Anna-Lena Ström
Journal:  J Mol Neurosci       Date:  2013-04-18       Impact factor: 3.444

Review 5.  The complex landscape of pancreatic cancer metabolism.

Authors:  Cristovão Marques Sousa; Alec C Kimmelman
Journal:  Carcinogenesis       Date:  2014-04-17       Impact factor: 4.944

6.  Altered expression of 3-betahydroxysterol delta-24-reductase/selective Alzheimer's disease indicator-1 gene in Huntington's disease models.

Authors:  Athina Samara; Mariarita Galbiati; Paola Luciani; Cristiana Deledda; Elio Messi; Alessandro Peri; Roberto Maggi
Journal:  J Endocrinol Invest       Date:  2014-06-11       Impact factor: 4.256

7.  Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin.

Authors:  Alice Grison; Fiamma Mantovani; Anna Comel; Elena Agostoni; Stefano Gustincich; Francesca Persichetti; Giannino Del Sal
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-19       Impact factor: 11.205

Review 8.  Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective.

Authors:  Luis M Valor
Journal:  Mol Neurobiol       Date:  2014-05-01       Impact factor: 5.590

9.  Genomic Instability Associated with p53 Knockdown in the Generation of Huntington's Disease Human Induced Pluripotent Stem Cells.

Authors:  Andrew M Tidball; M Diana Neely; Reed Chamberlin; Asad A Aboud; Kevin K Kumar; Bingying Han; Miles R Bryan; Michael Aschner; Kevin C Ess; Aaron B Bowman
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

Review 10.  P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes?

Authors:  Aleksandra Szybińska; Wiesława Leśniak
Journal:  Aging Dis       Date:  2017-07-21       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.